Lv11
50 积分 2025-12-12 加入
Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)
6天前
已关闭
Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)
6天前
已关闭
Generation of tolerogenic antigen-presenting cells in vivo via the delivery of mRNA encoding PDL1 within lipid nanoparticles
8天前
已完结
Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies
9天前
已完结
Drug delivery systems for RNA therapeutics
10天前
已完结
Advances in oligonucleotide drug delivery
10天前
已完结
Nanomedicine for the Treatment of Rheumatoid Arthritis
10天前
已完结
Systemic reprogramming of tumour immunity via IL-10-mRNA nanoparticles
10天前
已完结
Implication of the deacetylase sirtuin-1 on synovial angiogenesis and persistence of experimental arthritis
11天前
已完结
Thermosensitive Light-Driven Smart Platform Induces Apoptosis of Fibroblast-like Synovial Cells and Macrophages for Enhanced Rheumatoid Arthritis Therapy
12天前
已完结
皖公网安备34019202002308
